Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: Putative role during viral fusion

Journal of Virology

Volumn 74, Issue 17, 2000, Pages 8038-8047

  Suarez, T ^a   Gallaher, W R ^a   Agirre, A ^a   Goni, F M ^a   Nieva, J L ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 41; VIRUS ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; FLUORESCENCE; GENE SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; MEMBRANE FUSION; MEMBRANE PERMEABILITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRUS GENE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CELL MEMBRANE; FLUOROMETRY; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MEMBRANE FUSION; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT;

EID: 0033869815     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.17.8038-8047.2000     Document Type: Article

References (49)

1. Structural basis for paramyxovirus-mediated membrane fusion
2. Identification of the fusion peptide of primate immunodeficiency viruses
3. A rapid and sensitive sub-micro phosphorus determination
4. HIV entry and its inhibition
5. Core structure of gp41 from the HIV-1 envelope glycoprotein
6. Structural study of the relationship between the rate of membrane fusion and the ability of the fusion peptide of influenza virus to perturb bilayers
7. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
8. Unwelcomed guests with master keys: How HIV uses chemokine receptors for cellular entry
9. Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket
10. 2+-induced fusion and destabilization of liposomes
11. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements
12. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41
13. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity
14. Capture of an early fusion-active conformation of HIV-1 gp41
15. Detection of a fusion peptide sequence in the transmembrane protein of the human immunodeficiency virus
16. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses
17. A general model for the transmembrane proteins of HIV and other retroviruses
18. The amino terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: Peptide conformation, orientation and aggregation
19. Virus-cell and cell-cell fusion
20. Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential
21. Enveloped viruses: A common mode of membrane fusion?
22. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
23. Fusion peptides derived from the HIV type I glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion
24. A simple method for displaying the hydropathic character of a protein
25. Non-random distribution of amino acids in the transmembrane segments of human type I single span membrane proteins
26. 2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes
27. The HIV-cell fusion reaction
28. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41
29. Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type I envelope glycoprotein-mediated membrane fusion
30. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: Different structural requirements for leakage and fusion
31. Destabilization and fusion of zwitterionic large unilamellar lipid vesicles induced by a β-type structure of the HIV-1 fusion peptide
32. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: Dose and sequence effects
33. Interbilayer lipid-mixing induced by the HIV-1 fusion peptide on large unilamellar vesicles: The nature of the nonlamellar intermediates
34. Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41
35. Characterization and modeling of membrane protein using sequence analysis
36. Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus
37. A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity
38. Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion
39. Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function
40. Use of resonance energy transfer to monitor membrane fusion
41. Structural biology of HIV
42. Atomic structure of the ectodomain from HIV-1 gp41
43. Membrane fusion
44. Protein folding in membranes: Determining energetics of peptide-bilayer interactions
45. Membrane protein folding and stability: Physical principles
46. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type-1 gp41 are potent inhibitors of virus infection
47. Structure of the haemag-glutinin membrane glycoprotein of influenza virus at 3 A resolution
48. Experimentally determined hydrophobicity scale for proteins at membrane interfaces
49. The preference of tryptophan for membrane interfaces